Wanbury Limited
Ankit Saxena currently serves as the Zonal Business Manager at Wanbury Limited since July 2023. Prior to this role, Ankit held positions at Cadila Pharmaceuticals Limited as a Sales Manager and at Cipla as a Regional Business Manager from June 2016 to November 2022. Ankit's professional journey began as a Business Development Executive at Panacea Biotec and includes experiences as a Business Executive at Wanbury Limited and an Area Business Manager at Ipca Laboratories Limited. Ankit holds a Bachelor of Science degree in PCM from D.A.V. P.G. College, earned between 2004 and 2007.
This person is not in any teams
This person is not in any offices
Wanbury Limited
Corporate Profile Towards Better Healthcare… Wanbury Limited, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. Wanbury’s major thrust area lies in Active Pharmaceutical Ingredient (API) sale in over 70 countries and Pan-India Formulation presence. Active Pharmaceutical Ingredient : Wanbury has a basket of over 13 API products. It is the largest manufacturer of Metformin with over 8500 tons per year. It is the largest exporter of Tramadol to the US market. Wanbury exports to over 50 countries, 65% of which comprises of regulated markets. Has two US-FDA approved multi-product API facilities and one plant under operation for semi-regulated markets. Has been the preferred supplier to some of the top five generic players of the world. Formulations : -Pan-India presence in ethical formulations with a portfolio of close to 70 brands. -Strong presence in gynecology, orthopedics, heamatinics, anti-diabetic, neutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics and general practitioner.